Clinical Trials Directory

Trials / Completed

CompletedNCT02703922

Validation of a Diagnostic Algorithm of Giant Cell Arteritis

Evaluation of a Diagnostic Strategy for Giant Cell Arteritis Based on Color Doppler Ultrasound of Temporal Arteries

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
165 (actual)
Sponsor
Poitiers University Hospital · Academic / Other
Sex
All
Age
50 Years
Healthy volunteers
Not accepted

Summary

Giant cell arteritis (GCA or temporal arteritis or cranial arteritis) or Horton disease is a vasculitis that occurs in older adults, affecting vessels of medium and large caliber. The diagnosis of GCA is a challenge for general practitioners and specialists. Since 1970, it is based on a combination of clinical, biological and histological signs. Temporal artery biopsy (TAB) was the reference method until recently. However, TAB has many drawbacks. Therefore, researches of the past 20 years have been intended to develop alternative diagnostic methods. This was notably the case of the color Doppler ultrasound (CDU) since the description by Wolfgang Schmidt of the halo sign. Although European and British recommendations put CDU as second line method, many authors suggest the possibility to do without TAB in many cases. In addition, many practitioners believe that it is not "ethical" to use an invasive unprofitable procedure like TAB, and have already been using CDU in their routine practice. However, no diagnostic algorithm validating this approach in a prospective series has been published to date. Therefore, the present study aim at validating a diagnostic algorithm of giant cell arteritis using color Doppler imaging of temporal arteries and cervicocephalic axes as first screening method.

Conditions

Interventions

TypeNameDescription
OTHERcolor Doppler ultrasound and TAB in case of CDU negativeScreening with color Doppler ultrasound followed by TAB in case of CDU negative

Timeline

Start date
2016-08-29
Primary completion
2020-02-10
Completion
2022-02-10
First posted
2016-03-09
Last updated
2024-12-13
Results posted
2024-12-13

Locations

6 sites across 1 country: France

Source: ClinicalTrials.gov record NCT02703922. Inclusion in this directory is not an endorsement.